Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02225522 · ClinicalTrials.gov registry record · NA
Genomic Sequencing in Acutely Ill Neonates
A NA study of Genetic Disease and Diseases/Diagnoses, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT02225522: Completed NA study of Genetic Disease and Diseases/Diagnoses, sponsored by Children's Mercy Hospital Kansas City.
NCT02225522 is a NA study of Genetic Disease and Diseases/Diagnoses that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 65 participants, below the 2,559-participant average among 30 other Genetic Disease trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02225522, a NA study of Genetic Disease and Diseases/Diagnoses, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of rapid next generation sequencing (NGS, such as whole genome sequencing1) with current practice to provide diagnostic or prognostic information or treatment guidance in acutely ill neonates and infants, particularly with respect to clinical care, cost and outcomes.
Primary Outcome
If randomized to the Rapid Genome Sequencing group, did the testing result in a molecular diagnosis for the patient with three weeks of receipt of the DNA in the lab.
Conditions Studied
Interventions
- OTHER Rapid whole genome sequencing (StatSeq)
Study Locations (1)
Missouri
- Children's Mercy Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02225522 record still lists
NCT02225522 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 2,559-participant average among 30 other Genetic Disease trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which Rapid whole genome sequencing (StatSeq) is the first listed.
NCT02225522 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02225522 about?
NCT02225522 is a clinical study titled "Genomic Sequencing in Acutely Ill Neonates". The purpose of this study is to compare the effectiveness of rapid next generation sequencing (NGS, such as whole genome sequencing1) with current practice to provide diagnostic or prognostic information or treatment guidance in acutely ill neonates and infants, particularly with respect to clinical...
What is the current status of trial NCT02225522?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2014-10. Estimated completion is 2016-09.
What conditions does trial NCT02225522 study?
This clinical trial studies the following conditions: Genetic Disease, Diseases/Diagnoses.
What interventions are being tested in trial NCT02225522?
The interventions under investigation include: Rapid whole genome sequencing (StatSeq) (OTHER).
Who is sponsoring clinical trial NCT02225522?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02225522 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02225522's enrollment target sits among peer trials
65 23rd of 30 higher than 8 of 30 other Genetic Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Genetic Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Large Language Models To Improve the Quality of Care of Cardiology Patients
RECRUITING · NA
-
Grand Valley State University (GVSU) Skills on Wheels
ACTIVE NOT RECRUITING · NA
-
Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease
ACTIVE NOT RECRUITING · NA
-
Overcoming Barriers to Accessing Genetic Medicine
ACTIVE NOT RECRUITING · NA
-
Pediatric Powered Wheelchair Standing Devices: An Exploratory Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia